Literature DB >> 27748661

Nasopharyngeal carcinoma: understanding its molecular biology at a fine scale.

Prosenjit Paul1, Himangshu Deka, Arup K Malakar, Binata Halder, Supriyo Chakraborty.   

Abstract

Among all cancers, the incidence of nasopharyngeal carcinoma (NPC) is quite high in the endemic regions. NPC is a head and neck cancer with poor survival rate, and is rare throughout most of the world but common in certain geographic areas, like southern Asia and some regions of North East India (Nagaland, Manipur, and Mizoram). A clear understanding of its etiology is still lacking, but NPC is widely suspected to be the result of both genetic susceptibility and exposure to environmental factors or Epstein-Barr virus infection. Diagnosis in the early stages needs a high index of clinical acumen, and, although most cross-sectional imaging investigations show the tumor with precision, confirmation is dependent on histology. This article reviews all related research reports on NPC histopathological classifications worldwide that have been published within the past 20 years. Genome-wide association studies suggested that there might be common disease mechanisms between that disease and NPC. Personalized management rules, quality assessment of life in patients, and an understanding of the essential mechanisms of recurrence could be directed toward research into recurrent NPC. Hence, this literature would offer otolaryngologists a deeper insight into the etiological and management aspects of NPC.

Entities:  

Mesh:

Year:  2018        PMID: 27748661     DOI: 10.1097/CEJ.0000000000000314

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  15 in total

1.  MicroRNA-21 depletion by CRISPR/Cas9 in CNE2 nasopharyngeal cells hinders proliferation and induces apoptosis by targeting the PI3K/AKT/MOTOR signaling pathway.

Authors:  Zhenzhou Xiao; Yan Chen; Zhaolei Cui
Journal:  Int J Clin Exp Pathol       Date:  2020-04-01

2.  Pretreatment 18F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma.

Authors:  Guang Ma; Bingxin Gu; Jiyi Hu; Lin Kong; Jiangang Zhang; Zili Li; Yangbo Xue; Jiade Lu; Junning Cao; Jingyi Cheng; Yingjian Zhang; Shaoli Song; Zhongyi Yang
Journal:  Ann Nucl Med       Date:  2021-04-28       Impact factor: 2.668

3.  LINC01515 promotes nasopharyngeal carcinoma progression by serving as a sponge for miR-325 to up-regulate CDCA5.

Authors:  Dan Liu; Hao Gong; Zezhang Tao; Shiming Chen; Yonggang Kong; Bokui Xiao
Journal:  J Mol Histol       Date:  2021-03-26       Impact factor: 2.611

Review 4.  Optimal management of oligometastatic nasopharyngeal carcinoma.

Authors:  Honggen Liu; Peiying Yang; Yingjie Jia
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-05       Impact factor: 2.503

5.  High expression of calreticulin indicates poor prognosis and modulates cell migration and invasion via activating Stat3 in nasopharyngeal carcinoma.

Authors:  Yaqian Han; Qianjin Liao; Heran Wang; Shan Rao; Pin Yi; Lu Tang; Yutong Tian; Linda Oyang; Hui Wang; Yingrui Shi; Yujuan Zhou
Journal:  J Cancer       Date:  2019-08-29       Impact factor: 4.207

6.  Association of Ambient Air Pollution with Nasopharyngeal Carcinoma Incidence in Ten Large Chinese Cities, 2006-2013.

Authors:  Tianan Yang; Yexin Liu; Weigang Zhao; Zhenjiao Chen; Jianwei Deng
Journal:  Int J Environ Res Public Health       Date:  2020-03-11       Impact factor: 3.390

7.  Genetic Polymorphisms of Long Non-coding RNA Linc00312 Are Associated With Susceptibility and Predict Poor Survival of Nasopharyngeal Carcinoma.

Authors:  Zhen Guo; Mei-Hua Bao; Yun-Xia Fan; Yan Zhang; Hai-Yan Liu; Xiao-Long Zhou; Ben Wu; Qing-Qing Lu; Bin-Sheng He; Xu-Ying Nan; Jiao-Yang Lu
Journal:  Front Cell Dev Biol       Date:  2021-07-16

8.  Expression of miR-34a and Ki67 in nasopharyngeal carcinoma and the relationship with clinicopathological features and prognosis.

Authors:  Linqi Wei; Chao Shi; Yonghong Zhang
Journal:  Oncol Lett       Date:  2019-12-13       Impact factor: 2.967

9.  Standardized nursing and clinical efficacy of OxyContin in reducing oral mucosal pain in patients with nasopharyngeal carcinoma: A randomized, double-blind, placebo-controlled study protocol.

Authors:  Nina Sun; Yunxia Li; Peihua Nie
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

10.  Downregulated long non-coding RNA SNHG7 restricts proliferation and boosts apoptosis of nasopharyngeal carcinoma cells by elevating microRNA-140-5p to suppress GLI3 expression.

Authors:  Yaozhang Dai; Xin Zhang; Haijie Xing; Yamin Zhang; Hua Cao; Jianzhong Sang; Ling Gao; Liuzhong Wang
Journal:  Cell Cycle       Date:  2020-01-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.